Production (Stage)
MediWound Ltd.
MDWD
$20.33
-$0.53-2.54%
NASDAQ
12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
---|---|---|---|---|---|
Revenue | 5.84M | 5.06M | 4.96M | 5.34M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 5.84M | 5.06M | 4.96M | 5.34M | |
Cost of Revenue | 4.94M | 4.62M | 4.36M | 4.62M | |
Gross Profit | 903.00K | 447.00K | 607.00K | 719.00K | |
SG&A Expenses | 4.00M | 3.03M | 2.87M | 2.79M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | 18.00K | -- | -- | 224.00K | |
Total Operating Expenses | 11.94M | 9.55M | 8.70M | 9.44M | |
Operating Income | -6.10M | -4.48M | -3.73M | -4.11M | |
Income Before Tax | -3.89M | -6.31M | -9.71M | -1.62M | |
Income Tax Expenses | 18.00K | -2.00K | 24.00K | 120.00K | |
Earnings from Continuing Operations | -3.91M | -6.31M | -9.73M | -1.74M | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -3.91M | -6.31M | -9.73M | -1.74M | |
EBIT | -6.10M | -4.48M | -3.73M | -4.11M | |
EBITDA | -5.90M | -4.13M | -3.37M | -3.92M | |
EPS Basic | -0.36 | -0.68 | -1.05 | -0.19 | |
Normalized Basic EPS | -0.23 | -0.42 | -- | -0.69 | |
EPS Diluted | -0.36 | -0.68 | -1.05 | -0.19 | |
Normalized Diluted EPS | -0.23 | -0.42 | -- | -0.69 | |
Average Basic Shares Outstanding | 10.79M | 9.28M | 9.23M | 9.22M | |
Average Diluted Shares Outstanding | 10.79M | 9.28M | 9.23M | 9.22M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |